Abbati Francesca, Altimari Annalisa, Corti Barbara, Dika Emi, Sperandi Francesca, Melotti Barbara
Department of Medical Oncology IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna Italy.
Laboratory of Oncologic Molecular Pathology IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna Italy.
Clin Case Rep. 2021 Mar 7;9(4):2200-2204. doi: 10.1002/ccr3.3982. eCollection 2021 Apr.
We report the case of a young woman who developed metastatic melanoma in the inguinal nodal region, which acquired chondrosarcomatous differentiation and preserved the BRAF mutation found in the primary tumor. The patient was treated with a BRAF/MEK inhibitor combination therapy (dabrafenib/trametinib), which was demonstrated to be effective and well-tolerated.